close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Regenerative Medical Technology Group

News headline image
RMTG's ISSCA Division Returns to São Paulo for a Second Brazil Congress, November 20-21
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG to Go Ringside at BKFC This Weekend to Capture Content for Its "RMTG Brief" Investor-Awareness Campaign
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
Cellgenic Establishes Local Commercial Presence in Brazil
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG's Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG's Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG Expands Cellgenic's Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG Expands Cellgenic Operations Into Argentina, Establishing a Strategic Commercial Hub for Regenerative Medicine in Latin America
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
RMTG Launches ISSCA AI(TM) Clinical Intelligence Platform, Extending Its Global Regenerative Medicine Network Into AI-Driven Clinical Infrastructure
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
News headline image
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
From Regenerative Medical Technology Group
Via ACCESS Newswire
Tickers RMTG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.